Data as of Sep 16
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 25.00, with a high estimate of 25.00 and a low estimate of 25.00. The median estimate represents a +85.19% increase from the last price of 13.50.
The current consensus among 1 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.